menu search

Medicinova stock up on european patent award

Medicinova Inc (NASDAQ:MNOV) stock started Wednesday on the front foot boosted by a patent award in Europe. The European Patent Office has given prote...

August 16, 2023, 10:15 am

Medicinova receives a new patent covering mn-001 for the treatment of scleroderma and systemic sclerosis in europe

LA JOLLA, Calif., Aug. 15, 2023 (GLOBE NEWSWIRE) — MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) an...

August 15, 2023, 11:00 pm

Medicinova receives a notice of allowance for a new patent covering mn-001 for the treatment of advanced nash in canada

LA JOLLA, Calif., April 30, 2023 (GLOBE NEWSWIRE) — MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) a...

April 30, 2023, 11:00 pm

Medicinova receives a notice of allowance for a new patent covering mn-001 and mn-002 for the treatment of scleroderma and systemic sclerosis in canada

LA JOLLA, Calif., Jan. 10, 2023 (GLOBE NEWSWIRE) — MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) an...

January 11, 2023, 3:00 am

Medicinova announces additional positive results regarding the effects of mn-001 (tipelukast) on serum lipid panel in type 2 diabetes and nafld patients presented at idf 2022 congress, the annual meet

LA JOLLA, Calif., Dec. 06, 2022 (GLOBE NEWSWIRE) — MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) an...

December 6, 2022, 11:00 pm

Medicinova announces additional positive results regarding the effects of mn-001 (tipelukast) on serum lipid panel in type 2 diabetes and nafld patients presented at idf 2022 congress, the annual meet

LA JOLLA, Calif., Dec. 06, 2022 (GLOBE NEWSWIRE) — MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) an...

December 6, 2022, 11:00 pm


Search within

Pages Search Results: